## **Core Concept**
The question tests knowledge on the management of persistent unstable ventricular arrhythmias, focusing on the immediate drug of choice. Unstable ventricular arrhythmias, such as ventricular tachycardia (VT) or ventricular fibrillation (VF), require prompt treatment to prevent progression to cardiac arrest. The management often involves antiarrhythmic drugs.

## **Why the Correct Answer is Right**
Lidocaine (also known as lignocaine) is frequently considered the drug of choice for acute management of ventricular tachycardia or ventricular fibrillation that is unresponsive to CPR, defibrillation, and a dose of adrenaline (epinephrine). It works by blocking sodium channels, which helps in stabilizing the cardiac membrane and reducing automaticity in the ventricles. This action is particularly useful in the setting of myocardial infarction or ischemia, where the heart is more susceptible to dangerous arrhythmias.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option C:** This option is blank and cannot be evaluated.
- **Option D:** This option is blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that for unstable ventricular arrhythmias, immediate actions include calling for help, starting CPR, and using an automated external defibrillator (AED) if available. Lidocaine is specifically useful because it does not depress myocardial contractility or cause significant vasodilation, making it safer in the acute setting.

## **Correct Answer:** . Lidocaine